Tarja Malm Selected Research

proteoglycan-degrading metalloendopeptidases

1/2016

ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tarja Malm Research Topics

Disease

33	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 06/2006
20	Inflammation (Inflammations) 01/2022 - 06/2006
15	Neuroinflammatory Diseases 01/2022 - 01/2011
11	Stroke (Strokes) 01/2022 - 08/2013
10	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2021 - 06/2011
6	Brain Ischemia (Cerebral Ischemia) 10/2019 - 01/2007
5	Migraine Disorders (Migraine) 01/2022 - 12/2017
5	Ischemia 01/2022 - 07/2014
5	Spinal Cord Injuries (Spinal Cord Injury) 01/2016 - 01/2007
4	Hypoxia (Hypoxemia) 01/2022 - 07/2008
4	Ischemic Stroke 06/2020 - 01/2017
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2019 - 08/2013
4	Infarction (Infarctions) 12/2017 - 08/2013
4	Gliosis 02/2015 - 06/2006
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2019 - 01/2007
2	Central Nervous System Diseases (CNS Diseases) 01/2022 - 01/2016
2	Infections 12/2021 - 10/2013
2	Memory Disorders (Memory Loss) 08/2021 - 01/2019
2	Cognitive Dysfunction 08/2021 - 08/2021
2	Disease Progression 01/2020 - 06/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2019
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 12/2014
2	Wounds and Injuries (Trauma) 06/2019 - 02/2015
2	Amyloid Plaque 01/2019 - 01/2008
2	Pain (Aches) 01/2019 - 01/2019
2	Neoplasms (Cancer) 12/2017 - 11/2015
2	Brain Injuries (Brain Injury) 01/2017 - 08/2013
2	Arthritis (Polyarthritis) 01/2016 - 01/2007
2	Contusions 02/2015 - 03/2014
2	Demyelinating Diseases (Demyelinating Disease) 02/2015 - 03/2014
2	Primary Immunodeficiency Diseases 05/2012 - 12/2010
1	Dementia (Dementias) 01/2022
1	Amyloidosis 08/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Parkinsonian Disorders (Parkinsonism) 01/2020
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2019

Drug/Important Bio-Agent (IBA)

13	Amyloid beta-PeptidesIBA 06/2022 - 06/2006
11	Amyloid (Amyloid Fibrils)IBA 08/2021 - 09/2009
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2011
8	Peptides (Polypeptides)IBA 08/2021 - 06/2006
7	Pharmaceutical PreparationsIBA 01/2022 - 12/2014
5	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2008
5	Transcription Factors (Transcription Factor)IBA 08/2016 - 01/2007
4	CytokinesIBA 01/2022 - 10/2013
4	LipopolysaccharidesIBA 01/2022 - 01/2018
3	Particulate MatterIBA 01/2022 - 01/2020
3	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2018
3	CholesterolIBA 10/2019 - 08/2013
3	Interleukin-33IBA 06/2019 - 02/2015
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2015 - 12/2014
3	Intravenous Immunoglobulins (IVIG)FDA Link 04/2014 - 12/2010
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2017
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 02/2021 - 10/2019
2	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2020 - 12/2017
2	Apolipoprotein E4IBA 10/2019 - 08/2013
2	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 01/2019 - 01/2015
2	Biological ProductsIBA 01/2019 - 12/2017
2	CopperIBA 01/2018 - 01/2017
2	LipidsIBA 12/2017 - 08/2013
2	Glutamic Acid (Glutamate)FDA Link 12/2017 - 01/2015
2	NF-kappa B (NF-kB)IBA 08/2016 - 01/2007
2	prolinedithiocarbamate (PDTC)IBA 02/2016 - 01/2007
2	EnzymesIBA 01/2016 - 01/2011
2	AntibodiesIBA 05/2012 - 12/2010
2	Glycogen Synthase (Synthase I)IBA 01/2011 - 01/2011
1	Oxygen (Dioxygen)IBA 01/2022
1	Air Pollutants (Pollutants, Air)IBA 01/2022
1	IsoenzymesIBA 01/2022
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2022
1	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 12/2021
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 12/2021
1	Ionotropic Glutamate ReceptorsIBA 12/2021
1	Neuroprotective AgentsIBA 10/2021
1	IronIBA 08/2021
1	AcidsIBA 08/2021
1	florbetapirIBA 08/2021
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 08/2021
1	Insulin (Novolin)FDA Link 02/2021
1	Protein AggregatesIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Chemokine CCL5IBA 01/2020
1	ArginaseIBA 10/2019
1	Interleukin-13IBA 10/2019
1	Proprotein Convertase 9IBA 10/2019
1	Protein CoronaIBA 01/2019
1	Calcitonin Gene-Related PeptideIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019

Therapy/Procedure

8	Therapeutics 01/2022 - 01/2011
2	Immunomodulation 02/2021 - 10/2015
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2021
1	Thrombectomy 06/2020
1	Activities of Daily Living (ADL) 01/2020
1	Treatment Delay 06/2019